Capricor Therapeutics (CAPR)
(Real Time Quote from BATS)
$7.78 USD
+0.11 (1.43%)
Updated Aug 6, 2025 02:28 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Capricor Therapeutics, Inc. has a market cap of $350.34M, which represents its share price of $7.67 multiplied by its outstanding shares number of 45.68M. As a small-cap company, CAPR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CAPR 7.78 +0.11(1.43%)
Will CAPR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CAPR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CAPR
FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks
Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
CAPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Capricor Therapeutics (CAPR) Reports Q4 Loss, Tops Revenue Estimates
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates
Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn into More Strength?
Other News for CAPR
Capricor Therapeutics to Present Second Quarter 2025 Financial Results and Recent Corporate ...
Biotech stocks rise following Prasad exit from FDA
12 Health Care Stocks Moving In Wednesday's Intraday Session
Capricor Therapeutics (CAPR) Sees Increased Bullish Options Activity
Capricor Therapeutics call volume above normal and directionally bullish